BioSpace News Archive

Drug Development

Alnylam’s RNAi Therapeutic Onpattro Shows Sustained Treatment in hATTR Study

Data shows the long-term efficacy and tolerability as well as the continued ability of Onpattro to reverse or halt neuropathy progression.

June 24, 2019
·
2 min read
·
Alex Keown
Policy

WHO Removes Controversial Opioid Guidelines Following Scathing Congressional Report

In a statement, WHO said it was discontinuing two guidelines that have been in place since 2011 and 2012 “in light of new scientific evidence that has emerged since the time of their publication” regarding the dangers of opioid abuse.

June 24, 2019
·
4 min read
·
Alex Keown
MorphoSys Presents Primary Analysis Data from L-MIND Study of Tafasitamab (MOR208) in combination with Lenalidomide in r/r DLBCL at ICML 2019

MorphoSys AG presented data from the primary analysis of the ongoing single-arm phase 2 clinical trial known as L-MIND in an oral presentation at the 15th International Conference on Malignant Lymphoma in Lugano, Switzerland.

June 24, 2019
·
7 min read
Noxxon Announces Leading International Pharma To Evaluate NOX-A12 In New Indication

NOXXON Pharma N.V. announced that a leading international pharmaceutical company amongst the top-10 pharmaceutical companies by worldwide revenue[1] has signed an agreement with NOXXON for the purpose of evaluating NOX-A12 in a new indication, which will remain undisclosed for competitive reasons.

June 24, 2019
·
3 min read
Expedeon AG introduces Lightning-Link® Metal Labelling Kits to support single cell analysis

Novel antibody labelling immunoassay technology for multiplex immune profiling addresses one of the fastest growing, billion-dollar life science market sectors

June 24, 2019
·
4 min read
Deals

Domain Therapeutics strengthens its scientific advisory board with leading GPCR and disease experts

Domain Therapeutics announces the appointment of world-renowned GPCR and drug discovery and development experts to its Scientific Advisory Board (SAB): Pr. Silvio Gutkind, Pr. Morley Hollenberg and Pr. Brigitte Kieffer.

June 24, 2019
·
5 min read
Deals

Medtronic Announces Cash Tender Offers for up to $4.175 Billion of Outstanding Debt Securities Issued by Medtronic, Inc., Medtronic Global Holdings S.C.A. and Covidien International Finance S.A.

Medtronic plc announced the commencement of two cash tender offers by its wholly-owned indirect subsidiaries, Medtronic, Inc., Medtronic Global Holdings S.C.A. and Covidien International Finance S.A. (“CIFSA” and, together with Medtronic, Inc.

June 24, 2019
·
13 min read
LDL-Cholesterol Does Not Predict Heart Risk Among Heart Patients

New Diagnostic Test, CERT, Improves Risk Prediction Over Standard Laboratory Tests

June 24, 2019
·
3 min read
Drug Development

Krystal Biotech Announces Positive Results from Phase 2 Clinical Trial (“GEM-2 study”) of KB103 and Receives Regenerative Medicine Advanced Therapy (“RMAT”) Designation from FDA for KB103

Krystal Biotech, Inc. announced positive results from its Phase 2 placebo-controlled clinical trial of KB103 (GEM-2) study and an update on results from Phase 1 (GEM-1) study.

June 24, 2019
·
10 min read
Deals

Mirati Therapeutics Announces Proposed Public Offering Of Common Stock On June 24, 2019

Mirati Therapeutics, Inc. announced that it has commenced an underwritten public offering of shares of its common stock.

June 24, 2019
·
4 min read